Vitruvias Therapeutics thyroid tablet recall gets FDA’s highest-risk rating - here’s what to check and what patients need to know
Credit: Shreya Biswas
A Class I recall has been issued by the FDA for Vitruvias Therapeutics’ Thyroid Tablets due to potential superpotency that could cause serious health risks. Consumers are advised on how to proceed with their current medication.